Volume 13, Number 12—December 2007
Research
Swine Workers and Swine Influenza Virus Infections
Gregory C. Gray*
, Troy McCarthy*, Ana W. Capuano*, Sharon F. Setterquist*, Christopher W. Olsen†, Michael C. Alavanja‡, and Charles F. Lynch*
, Troy McCarthy*, Ana W. Capuano*, Sharon F. Setterquist*, Christopher W. Olsen†, Michael C. Alavanja‡, and Charles F. Lynch*
Table 3
Serologic evidence for influenza infections during the 24 months of follow-up
| Period | N | >4-fold increase |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Swine influenza (H1N1) |
Swine influenza (H1N2) |
Human influenza (H1N1) |
|||||||
| n | Reported ILI,* n (%) | n | Reported ILI,* n (%) | n | Reported ILI,* n (%) | ||||
| Enrollment to 12-mo follow-up | 658 | 26 | 3 (11.5) | 17 | 7 (41.2) | 10 | 1 (10) | ||
| 12- to 24--mo follow-up | 586 | 109 | 18 (16.5) | 16 | 2 (12.5) | 19 | 3 (15.8) | ||
| Enrollment to 24-mo follow-up | 654 | 141 | 31 (22) | 23 | 2 (8.7) | 20 | 3 (15) | ||
| Any increase between pairs of serum samples† | 726 | 180 | 38 (21.1) | 37 | 9 (24.3) | 32 | 4 (12.5) | ||
*Percentage of the participants who demonstrated a ≥4-fold increase in titer who also self-reported an influenza-like illness (ILI) during follow–up.
†From enrollment to 12 mo, 12 to 24 mo, or enrollment to 24 mo, among participants who permitted serum sample collections at least 2 times during the study.
Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.